Financials Aceso Life Science Group Limited

Equities

474

KYG0070S1066

Heavy Machinery & Vehicles

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.159 HKD +2.58% Intraday chart for Aceso Life Science Group Limited +1.92% +41.96%

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 1,396 1,163 1,224 1,574 472.4 1,314
Enterprise Value (EV) 1 2,219 3,466 3,011 3,660 2,765 3,634
P/E ratio -3.13 x -2.85 x -4.09 x -3.59 x -1.15 x -4.93 x
Yield - - - - - -
Capitalization / Revenue 5.57 x 6.63 x -7.73 x 16.1 x 2.78 x 6.35 x
EV / Revenue 8.86 x 19.8 x -19 x 37.3 x 16.3 x 17.6 x
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 0.5 x 0.44 x 0.49 x 0.66 x 0.24 x 0.85 x
Nbr of stocks (in thousands) 4,898,038 5,284,799 6,091,887 6,931,887 7,381,777 7,381,777
Reference price 2 0.2850 0.2200 0.2010 0.2270 0.0640 0.1780
Announcement Date 7/19/18 7/29/19 7/29/20 7/22/21 7/28/22 7/26/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 250.4 175.5 -158.5 98 170 207
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -538.4 -480.6 -267.2 -323 -555 -213
Net income 1 -444.9 -380.9 -283.7 -376 -370 -264
Net margin -177.66% -217.07% 179.05% -383.67% -217.65% -127.54%
EPS 2 -0.0911 -0.0771 -0.0491 -0.0633 -0.0555 -0.0361
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/19/18 7/29/19 7/29/20 7/22/21 7/28/22 7/26/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 823 2,303 1,786 2,086 2,293 2,320
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) -15.9% -14.3% -10.5% -12.6% -20.4% -7.7%
ROA (Net income/ Total Assets) -10.1% -7.87% -5.25% -6.21% -9.59% -3.31%
Assets 1 4,389 4,838 5,408 6,050 3,858 7,973
Book Value Per Share 2 0.5700 0.5000 0.4100 0.3400 0.2700 0.2100
Cash Flow per Share 2 0.1600 0.0500 0.0600 0.0300 0.0300 0.0300
Capex 1 72.6 70.7 36.2 15 57 47
Capex / Sales 28.98% 40.31% -22.83% 15.31% 33.53% 22.71%
Announcement Date 7/19/18 7/29/19 7/29/20 7/22/21 7/28/22 7/26/23
1HKD in Million2HKD
Estimates
  1. Stock Market
  2. Equities
  3. 474 Stock
  4. Financials Aceso Life Science Group Limited